As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the ...

Artificial intelligence is revolutionizing drug discovery and antibody engineering, accelerating the creation of new ...

LifeTracer is not a universal life detector. Rather, it provides a foundation for interpreting complex organic mixtures. The Bennu findings remind us that life-friendly chemistry may be widespread ...

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection.

Scientists discovered that the protein RPA plays a critical and previously unconfirmed role in stimulating telomerase to ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

RNA is a central biological macromolecule, now widely harnessed in medicine and nanotechnology. Like proteins, RNA function often depends on its precise three-dimensional structure. A recent study ...

Katalyze AI today announced the appointment of Hannes Bretschneider as Chief AI Officer. Hannes will lead the development of Agentic AI architecture and expand the company's capabilities across ...

A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled "SAMP ...